Accendra Health, Inc.
ACH
$3.23
$0.072.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -6.84% | 2.01% | 1.52% | 3.26% | 5.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.84% | 2.01% | 1.52% | 3.26% | 5.65% |
| Cost of Revenue | -1.38% | 6.54% | 5.63% | 3.76% | 4.85% |
| Gross Profit | -12.91% | -2.92% | -2.89% | 2.71% | 6.56% |
| SG&A Expenses | -2.72% | 0.58% | -2.38% | -0.77% | -2.90% |
| Depreciation & Amortization | 292.02% | 320.99% | -- | -25.28% | -47.82% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.56% | 7.42% | 0.81% | 1.33% | 0.28% |
| Operating Income | -113.01% | -61.73% | 10.30% | 36.57% | 227.48% |
| Income Before Tax | -200.96% | 97.36% | -479.44% | -795.90% | 72.07% |
| Income Tax Expenses | -515.74% | -95.06% | 750.83% | 58.87% | 73.23% |
| Earnings from Continuing Operations | -69.76% | 97.15% | -544.65% | -1,143.28% | 71.55% |
| Earnings from Discontinued Operations | -- | -231.16% | -931.07% | -3,019.61% | -149.29% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.11% | 80.98% | -1,076.79% | -2,623.21% | -14.15% |
| EBIT | -113.01% | -61.73% | 10.30% | 36.57% | 227.48% |
| EBITDA | -40.08% | 40.35% | 6.88% | 8.71% | 3.51% |
| EPS Basic | 73.83% | 80.96% | -1,073.45% | -2,616.04% | -12.77% |
| Normalized Basic EPS | -266.02% | -122.75% | 24.88% | -58.78% | 313.74% |
| EPS Diluted | 73.89% | 80.83% | -1,073.45% | -2,601.87% | -13.01% |
| Normalized Diluted EPS | -266.02% | -122.75% | 27.13% | -58.78% | 313.74% |
| Average Basic Shares Outstanding | -1.09% | -0.05% | 0.26% | 0.27% | 1.24% |
| Average Diluted Shares Outstanding | -1.09% | -0.05% | -1.51% | 0.27% | 1.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |